The Clinical and Prognostic Relevance of Histopathologic Classification in Hodgkin’s Disease

  • Michael H. Bennett
  • Kenneth A. MacLennan
  • Bryan Vaughan Hudson
  • Gillian Vaughan Hudson

Abstract

Few diseases have caused such confusion or generated as much controversy as Hodgkin’s disease. The debate over this disease has centered not only on terminology (by 1933 Wallhauser1 could find 52 synonyms for this condition in the literature), but also upon the basic nature of the disease process. The view that Hodgkin’s disease was inflammatory was held by many workers. Some believed it was an atypical reaction to the Tubercle bacillus,2 others were convinced it was a malignant tumor.3, 4 Modern karyotypic and culture studies have confirmed Hodgkin’s disease to be a neoplastic process,5,9 but although many theories have been proposed,6, 9,1016 the precise identity of the malignant cell has remained obscure.

Keywords

Albumin Lymphoma Anemia Germinal Oncol 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Wallhauser A: Hodgkin’s disease. Arch Pathol 16:552–562; 672–712, 1933Google Scholar
  2. 2.
    Sternberg C: Uber eine eigenartige unter dem Bilde der Pseudoleukamie verlaufende Tuberculose des lymphatischen Apparates. Ztschr Heilk 19:21–90, 1898Google Scholar
  3. 3.
    Mallory FB: Principles of pathologic history. Philadelphia, W.B. Saunders, 1914Google Scholar
  4. 4.
    Warthin AS: Genetic neoplastic relationships of Hodgkin’s disease, aleukemic and leukemic lymphoblastoma, and mycosis fungoides. Ann Surg 93:153–161, 1931PubMedCrossRefGoogle Scholar
  5. 5.
    Spriggs AI: Clonal proliferation in Hodgkin’s disease. Lancet 1:857, 1971PubMedCrossRefGoogle Scholar
  6. 6.
    Kaplan HS, Gartner S: “Sternberg-Reed” giant cells of Hodgkin’s disease: Cultivation in vitro, heterotransplantation and characterization as neoplastic macrophages. Int J Cancer 9:511–525, 1975Google Scholar
  7. 7.
    Fukuhara S, Rowley JD: Chromosome 14 translocations in non-Burkitt lymphomas. Int J Cancer 22:14–21, 1978PubMedCrossRefGoogle Scholar
  8. 8.
    Diehl V, Kirchner HH, Burrichter H, et al: Characteristics of Hodgkin’s disease derived cell lines. Cancer Treat Rep 66:615–632, 1982PubMedGoogle Scholar
  9. 9.
    Lawler SD, Swansbury GJ: Cytogenetic Studies in Hodgkin’s Disease, in Hodgkin’s Disease (eds): Selby P and McElwain TJ. Blackwell Scientific Publications. 43–67, 1987Google Scholar
  10. 10.
    Thompson AD: The thymic origin of Hodgkin’s disease. Brit J Cancer 9:37–50, 1955CrossRefGoogle Scholar
  11. 11.
    Curran RC, Jones EL: Hodgkin’s disease: An immunohistochemical and histological study. J Pathol 125:39–51, 1978PubMedCrossRefGoogle Scholar
  12. 12.
    Kadin ME: Possible origin of the Reed-Sternberg cell from an interdigitating reticulum cell. Cancer Treat Rep 60:601–608, 1982Google Scholar
  13. 13.
    Stein H, Gerdes J, Schwab U, et al: Identification of Hodgkin and Sternberg-Reed cells as a unique cell type derived from a newly detected small cell population. Int J Cancer 30:445–459, 1982PubMedCrossRefGoogle Scholar
  14. 14.
    Stein H, Mason DY, Gerdes J, et al: The expression of the Hodgkin’s disease associated antigen Ki-1 in reactive and neoplastic lymphoid tissue-Evidence that Reed-Sternberg cells and histiocytic malignancies are derived from activated lymphoid cells. Blood 66:848–858, 1985PubMedGoogle Scholar
  15. 15.
    Linch DC, Berliner N, O’Flynn K, et al: Hodgkin’s cell leukaemia of B-cell origin. Lancet 1:78–80, 1985PubMedCrossRefGoogle Scholar
  16. 16.
    Bucsky P: Hodgkin’s disease: The Sternberg-Reed cell. Blut 55:413–420, 1987PubMedCrossRefGoogle Scholar
  17. 17.
    Rosenthal SR: Significance of tissue lymphocytes in the prognosis of lymphogranulomatosis. Arch Pathol 21:628–646, 1936Google Scholar
  18. 18.
    Jackson H, Jr, Parker F, Jr: Hodgkin’s Disease and Allied Disorders. Oxford University Press, (1947)Google Scholar
  19. 19.
    Smetana HF, Cohen BM: Mortality in relation to histologic type in Hodgkin’s disease. Blood 11:211–224, 1956PubMedGoogle Scholar
  20. 20.
    Jellifife AM, Thompson AD: The prognosis in Hodgkin’s disease. Br J Cancer 9:21–36, 1955CrossRefGoogle Scholar
  21. 21.
    Lukes RJ: Relationship of histologic features to clinical stages in Hodgkin’s disease. Am J Roentgenol 90:944–955, 1963Google Scholar
  22. 22.
    Lukes RJ: Criteria for involvement of lymph node, bone marrow, spleen and liver in Hodgkin’s disease. Cancer Res 31:1755–1767, 1971PubMedGoogle Scholar
  23. 23.
    Lukes RJ, Butler JJ: The pathology and nomenclature of Hodgkin’s disease. Cancer Res 26:1063–1081, 1966PubMedGoogle Scholar
  24. 24.
    Lukes RJ, Butler JJ, Hicks EB: Natural history of Hodgkin’s disease as related to its pathologic picture. Cancer 34:317–344, 1966CrossRefGoogle Scholar
  25. 25.
    Lukes RJ, Craver LF, Hall TC, et al: Report of the nomenclature committee. Cancer Res 26:1311, 1966Google Scholar
  26. 26.
    Cross RM: A clinicopathologic study of nodular sclerosing Hodgkin’s disease. J Clin Pathol 21:303–310, 1968PubMedCrossRefGoogle Scholar
  27. 27.
    Cross RM: Hodkin’s disease: Histological classification and diagnosis. J Clin Pathol 22:165–182, 1969PubMedCrossRefGoogle Scholar
  28. 28.
    Glatstein E: Hodgkin’s disease and non-Hodgkin’s lymphomas: How important is histology? Front Radiation Ther Onc 9:203–216, 1974Google Scholar
  29. 29.
    Kaplan HS: Hodgkin’s disease and other human malignant lymphomas: Advances and prospects-GHA Clowes memorial lecture. Cancer Res 36:3863–3878, 1976PubMedGoogle Scholar
  30. 30.
    Torti FM, Dorfman RF, Rosenberg SA, Kaplan HS: The changing significance of histology in Hodgkin’s disease. Proc Am Assoc Cancer Res and ASCO 20:401 (C-454), 1979Google Scholar
  31. 31.
    Hoppe RT, Rosenberg SA, Kaplan HS, Cox RS: Prognostic factors in pathological stage IIIa Hodgkin’s disease. Cancer 46; 1240–1246, 1980.PubMedCrossRefGoogle Scholar
  32. 32.
    Fuller LM, Gamble JF, Velazquez WS, et al: Evaluation of the significance of prognostic factors in stage III Hodgkin’s disease treated with MOPP and radiotherapy. Cancer 45:1352–1364, 1980PubMedCrossRefGoogle Scholar
  33. 33.
    Kaplan HS : Hodgkin’s Disease, Harvard University Press, 1980Google Scholar
  34. 34.
    Colby TV, Hoppe RT, Warnke RA: Hodgkin’s disease: A clinicopathologic study of 659 cases. Cancer 49:1848–1858, 1981CrossRefGoogle Scholar
  35. 35.
    Hoppe RT, Cox RS, Rosenberg SA, Kaplan HS: Prognostic factors in pathologic stage III Hodgkin’s disease. Cancer Treat Rep 66:743–749, 1982PubMedGoogle Scholar
  36. 36.
    Jelliffe AM, Vaughan Hudson G: The evolution of the British National Lymphoma Investigation. Clin Radiol 32:483–489, 1980CrossRefGoogle Scholar
  37. 37.
    Bennett MH, Tu A, Vaughan Hudson B: Analysis of Grade 1 Hodgkin’s disease. Clin Radiol 32:491–498, 1981PubMedCrossRefGoogle Scholar
  38. 38.
    Strum SB, Rappaport H: Interrelations of the histologic subtypes of Hodgkin’s disease. Arch Pathol 91:127–134, 1971PubMedGoogle Scholar
  39. 39.
    Neiman RS: Current problems in Histopathologic diagnosis and classification of Hodgkin’s disease. Path Annual 13(2):289–328, 1978Google Scholar
  40. 40.
    Keller AR, Kaplan HS, Lukes RJ, Rappaport H: Correlation of histopathology with other prognostic indicators in Hodgkin’s disease. Cancer 22:487–499, 1968PubMedCrossRefGoogle Scholar
  41. 41.
    Coppleson LW, Rappaport H, Strum SB, Rose J: Analysis of the Rye classification of Hodgkin’s disease. The prognostic significance of cellular composition. J Nat Cancer Inst 5:379–390, 1973Google Scholar
  42. 42.
    Patchevsky AS, Brodovsky H, Southard M, Men-duke H: Hodgkin’s disease. A clinical and pathological study of 235 cases. Cancer 32:150–161, 1973CrossRefGoogle Scholar
  43. 43.
    Cionini L, Argonini L, Biti GP, Bondi R: Prognostic significance of histologic subdivision of Hodgkin’s disease nodular sclerosis. Acta Radiologica (Oncology) 17:65–73, 1978CrossRefGoogle Scholar
  44. 44.
    Carbone A: Histologic subclassification of nodular sclerosis Hodgkin’s disease. Tumori 65:743–751, 1979PubMedGoogle Scholar
  45. 45.
    Mann RB, Jaffe ES, Berard CW: Malignant lymphomas; a conceptual understanding of morphologic diversity. Am J Pathol 94:103–192, 1979Google Scholar
  46. 46.
    DeVita VT: The consequences of chemotherapy of Hodgkin’s disease. The tenth David A. Karnovsky lecture. Cancer 47:1–13, 1981PubMedCrossRefGoogle Scholar
  47. 47.
    DeVita VT, Hubbard SM: The curative potential of chemotherapy in the treatment of Hodgkin’s disease and non-Hodgkin’s lymphomas, Rosenberg SA and Kaplan HS, (eds): Malignant Lymphomas Aetiology, Immunology, Pathology, Treatment. Orlando Fl Academic Press 379–418, 1982Google Scholar
  48. 48.
    Bennett MH, MacLennan KA, Easterling MJ, et al: The prognostic significance of cellular subtypes in nodular sclerosing Hodgkin’s disease: An analysis of 271 non-laparotomised cases. Clin Radiol 34:497–501, 1983PubMedCrossRefGoogle Scholar
  49. 49.
    Bennett MH, MacLennan KA, Easterling MJ, et al: Analysis of histological subtypes of Hodgkin’s disease in relation to prognosis and survival, in (eds): Quaglino D and Hayhoe FGJ The Cytobiology of leukaemias and lymphomas, Serono publications from Raven Press, 1985 20:15–32Google Scholar
  50. 50.
    MacLennan KA, Bennett MH, Tu A, et al: Prognostic significance of cytologic subdivision in nodular sclerosing Hodgkin’s disease: An analysis of 1156 patients. In Malignant lymphomas and Hodgkin’s disease: Experimental and therapeutic advances. Cavalli F, Bonadonna G, Rozencweig M. (eds): Boston, Martinus Nijhoff Publishing, 1985, 187–200CrossRefGoogle Scholar
  51. 51.
    Suster S: Transformation of Hodgkin’s disease into malignant fibrous histiocytoma. Cancer 57:264–268, 1986PubMedCrossRefGoogle Scholar
  52. 52.
    Butler JJ: The Lukes-Butler classification of Hodgkin’s disease revisited, in Bennett JM (ed): Controversies in the management of lymphomas. Boston, Martinus Nijhoff 1983 1–18CrossRefGoogle Scholar
  53. 53.
    Strickler JG, Michie SA, Warnke RA, Dorfman RF. The “syncytial variant” of nodular sclerosing Hodgkin’s disease. Am J Surg Pathol 10:470–477, 1986PubMedCrossRefGoogle Scholar
  54. 54.
    Suchi T, Lennert K, Tu L-Y, et al: Histopathology and immunohistochemistry of peripheral T cell lymphomas: a proposal for their classification. J Clin Pathol 40:995–1015, 1987PubMedCrossRefGoogle Scholar
  55. 55.
    Trudel MA, Krikorian JG, Neiman RS: Lymphocyte predominance Hodgkin’s disease: A clinicopathologic reassessment. Cancer 59:99–106, 1987PubMedCrossRefGoogle Scholar
  56. 56.
    MacLennan KA, Vaughan Hudson B, Jelliffe AM, et al: The pretreatment peripheral blood lymphocyte count in 1100 patients with Hodgkin’s disease: The prognostic significance and the relationship to the presence of systemic symptoms. Clin Oncol 7:333–339, 1981PubMedGoogle Scholar
  57. 57.
    MacLennan KA, Vaughan Hudson B, Easterling MJ, et al: The presentation Haemoglobin level in 1103 patients with Hodgkin’s disease. Clin Radiol 34:491–495, 1983PubMedCrossRefGoogle Scholar
  58. 58.
    Vaughan Hudson B, MacLennan KA, Bennett MH, et al: Systemic disturbance in Hodgkin’s disease and its relation to histopathology and prognosis. Clin Radiol 38:257–261, 1987PubMedCrossRefGoogle Scholar
  59. 59.
    Dorfman RF, Colby TV: The pathologists role in the management of patients with Hodgkin’s disease. Cancer Treat Rep 66:675–680, 1982PubMedGoogle Scholar
  60. 60.
    Vaughan Hudson B, MacLennan KA, Easterling MJ, et al: The prognostic significance of age in Hodgkin’s disease: Examination of 1500 patients. Clin Radiol 34:503–506, 1983PubMedCrossRefGoogle Scholar
  61. 61.
    Haybittle JL, Hayhoe FGJ, Easterling MJ, et al: Review of British National Lymphoma Investigation studies of Hodgkin’s disease and development of prognostic index. Lancet 1:967–972, 1985PubMedCrossRefGoogle Scholar
  62. 62.
    Harrison CV: Benign Hodgkin’s disease (Hodgkin’s paragranuloma). J Path Bact 64:513–518, 1952PubMedCrossRefGoogle Scholar
  63. 63.
    Lumb G: Tumours of lymphoid tissue. E & S Livingstone Ltd. Edinburgh, 1954, 58–63Google Scholar
  64. 64.
    Wright CJE: Hodgkin’s Paragranuloma. Cancer 9:773–777, 1956PubMedCrossRefGoogle Scholar
  65. 65.
    Wright CJE: The “benign” form of Hodgkin’s disease (Hodgkin’s paragranuloma). J Path Bact 80:157–171, 1960PubMedCrossRefGoogle Scholar
  66. 66.
    Regula DP, Hoppe RT, Weiss LM: Nodular and diffuse types of lymphocyte predominant Hodgkin’s disease. N Engl J Med 318:214–219, 1988PubMedCrossRefGoogle Scholar
  67. 67.
    Poppema S, Kaiserling E, Lennert K: Hodgkin’s disease with lymphocytic predominance, nodular type (nodular paragranuloma) and progressively transformed germinal centres—a cytohistological study. Histopathology 3:295–308, 1979PubMedCrossRefGoogle Scholar
  68. 68.
    Burns BF, Colby TV, Dorfman RF: Differential diagnostic features of nodular L & H Hodgkin’s disease, including progressive transformation of germinal centres. Am J Surg Pathol 8:253–261, 1984PubMedCrossRefGoogle Scholar
  69. 69.
    Osbourne BM, Butler JJ: Clinical implications of progressive transformation of germinal centres. Am J Surg Pathol 8:725–733, 1984CrossRefGoogle Scholar
  70. 70.
    Regula DP, Weiss LM, Warnke RA, Dorfman RF: Lymphocyte predominance Hodgkin’s disease: A reappraisal based upon histological and immunophenotypical findings in relapsing cases. Histopathology 11:1107–1120, 1987PubMedCrossRefGoogle Scholar
  71. 71.
    Neiman RS, Rosen PJ, Lukes RJ: Lymphocyte-depletion Hodgkin’s disease, a clinicopathologic entity. N Eng J Med 288:751–755, 1973CrossRefGoogle Scholar
  72. 72.
    Bearman RM, Pangalis GA, Rappaport H: Hodgkin’s disease, lymphocyte depletion type. A clinicopathologic study of 39 patients. Cancer 41:293–302, 1978PubMedCrossRefGoogle Scholar
  73. 73.
    Kant JA, Hubbard SM, Longo DL, et al: The pathologic and Clinical heterogeneity of lymphocyte depleted Hodgkin’s disease. J Clin Oncol 4:284–294, 1986PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1989

Authors and Affiliations

  • Michael H. Bennett
  • Kenneth A. MacLennan
  • Bryan Vaughan Hudson
  • Gillian Vaughan Hudson

There are no affiliations available

Personalised recommendations